Multi-omics analysis identified LGALS1 (Galectin-1) as a novel therapeutic target for clear cell renal cell carcinoma via targeting epithelial or endothelial cells
{{output}}
Background: Since the pathophysiology of clear cell renal cell carcinoma (ccRCC) was still unknown, finding novel therapeutic targets to support current treatment approaches was crucial. ... ...
